Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century

[1]  Anouk L. M. Eikendal,et al.  Adverse Drug Reactions to Guideline-Recommended Heart Failure Drugs in Women: A Systematic Review of the Literature. , 2019, JACC. Heart failure.

[2]  G. Trifirò,et al.  Gender Differences in Outpatient Pediatric Drug Utilization: A Cohort Study From Southern Italy , 2019, Front. Pharmacol..

[3]  G. Trifirò,et al.  The economic burden of preventable adverse drug reactions: a systematic review of observational studies , 2018, Expert opinion on drug safety.

[4]  K. Taxis,et al.  Does patient reporting lead to earlier detection of drug safety signals? A retrospective comparison of time to reporting between patients and healthcare professionals in a global database , 2018, British journal of clinical pharmacology.

[5]  H. Taavola,et al.  Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre , 2017, Drug Safety.

[6]  G. N. Norén,et al.  A method for data‐driven exploration to pinpoint key features in medical data and facilitate expert review , 2017, Pharmacoepidemiology and drug safety.

[7]  Mitja Lainscak,et al.  Under-representation of elderly and women in clinical trials. , 2017, International journal of cardiology.

[8]  Lennart Holm,et al.  Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden , 2017, Pharmacoepidemiology and drug safety.

[9]  N. Saikia,et al.  Gender Difference in Health-Care Expenditure: Evidence from India Human Development Survey , 2016, PloS one.

[10]  K. Järbrink,et al.  Sex differences in health care consumption in Sweden: A register-based cross-sectional study , 2016, Scandinavian journal of public health.

[11]  S. Wilkes,et al.  Adverse drug reaction reports of patients and healthcare professionals—differences in reported information , 2015, Pharmacoepidemiology and drug safety.

[12]  E. Russo,et al.  Adherence to therapy and adverse drug reactions: is there a link? , 2014, Expert opinion on drug safety.

[13]  M. Lapeyre-Mestre,et al.  No differences between men and women in adverse drug reactions related to psychotropic drugs: a survey from France, Italy and Spain , 2014, Fundamental & clinical pharmacology.

[14]  K. Bingefors,et al.  Women and men report different behaviours in, and reasons for medication non-adherence: a nationwide Swedish survey , 2012, Pharmacy practice.

[15]  Ebba Holme Hansen,et al.  Global Patterns of Adverse Drug Reactions Over a Decade , 2012, Drug Safety.

[16]  Lise Aagaard,et al.  Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™. , 2012, Drug safety.

[17]  L. Borgquist,et al.  Licit prescription drug use in a Swedish population according to age, gender and socioeconomic status after adjusting for level of multi-morbidity , 2012, BMC Public Health.

[18]  Kristina Star,et al.  Suspected Adverse Drug Reactions Reported For Children Worldwide , 2011, Drug safety.

[19]  Anthony Avery,et al.  Adverse Drug Reaction Reporting in the UK , 2010, Drug safety.

[20]  E. Hansen,et al.  Adverse Drug Reactions in the Paediatric Population in Denmark , 2010, Drug safety.

[21]  Anika Ashok,et al.  ICH Harmonised Tripartite Guideline , 2009 .

[22]  M. Lindquist.  VigiBase, the WHO Global ICSR Database System: Basic Facts , 2008 .

[23]  V. Menon,et al.  Enrollment of women in National Heart, Lung, and Blood Institute-funded cardiovascular randomized controlled trials fails to meet current federal mandates for inclusion. , 2008, Journal of the American College of Cardiology.

[24]  W. Rascher,et al.  Women encounter ADRs more often than do men , 2008, European Journal of Clinical Pharmacology.

[25]  D. Malone,et al.  Gender and age differences in medications dispensed from a national chain drugstore. , 2008, Journal of women's health.

[26]  M. Redaélli,et al.  Sex differences in treatment patterns of six chronic diseases: an analysis from the German statutory health insurance. , 2008, Journal of women's health.

[27]  G. Niklas Norén,et al.  Duplicate detection in adverse drug reaction surveillance , 2007, Data Mining and Knowledge Discovery.

[28]  F. Rodríguez‐Artalejo,et al.  Gender differences in the utilization of health-care services among the older adult population of Spain , 2006, BMC public health.

[29]  G. Anderson.  Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. , 2005, Journal of women's health.

[30]  Rosaly Correa-de-Araujo,et al.  Gender differences in drug use and expenditures in a privately insured population of older adults. , 2005, Journal of women's health.

[31]  M. Pirmohamed,et al.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.

[32]  M. Cesari,et al.  Adverse Drug Reactions as Cause of Hospital Admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA) , 2002, Journal of the American Geriatrics Society.

[33]  M. Lapeyre-Mestre,et al.  Gender differences in adverse drug reactions: analysis of spontaneous reports to a Regional Pharmacovigilance Centre in France , 2002, Fundamental & clinical pharmacology.

[34]  Karl-Heinz Ladwig,et al.  Gender differences of symptom reporting and medical health care utilization in the German population , 2000, European Journal of Epidemiology.

[35]  R. Mann,et al.  Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. , 1998, British journal of clinical pharmacology.

[36]  S. Schappert,et al.  Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 1997. , 1997, Vital and health statistics. Series 13, Data from the National Health Survey.

[37]  M. Boemi,et al.  Adverse Drug Events as a Cause of Hospitalization in Older Adults , 2012, Drug Safety.

[38]  B. Stricker,et al.  Sex-related differences in hospital admissions attributed to adverse drug reactions in the Netherlands. , 2011, British journal of clinical pharmacology.

[39]  D. Mattison,et al.  Sex Differences in Pharmacokinetics and Pharmacodynamics , 2009, Clinical pharmacokinetics.

[40]  G. Anderson.  Gender differences in pharmacological response. , 2008, International review of neurobiology.

[41]  C. Burt,et al.  Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments: United States, 2001-02. , 2006, Vital and health statistics. Series 13, Data from the National Health Survey.

[42]  L. Hazell,et al.  Under-Reporting of Adverse Drug Reactions , 2006, Drug safety.